Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Physical Growth”

Showing 20 of 0 results

Not applicableStudy completedNCT06869200
What this trial is testing

Study on the Use of a Concentrated Growth Factor Preparation Kit for the Treatment of Knee Osteoarthritis

Who this might be right for
Knee Osteoarthritis
Guangdong Hongzhi Health Technology 104
Early research (Phase 1)UnknownNCT00916292
What this trial is testing

Safety Study of Topical Human FGF-1 for Wound Healing

Who this might be right for
Diabetic Foot Ulcers
Phage Pharmaceuticals, Inc. 8
Testing effectiveness (Phase 2)WithdrawnNCT02747797
What this trial is testing

Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations

Who this might be right for
Advanced Cancer
Teresa Helsten, MD
Large-scale testing (Phase 3)UnknownNCT04475224
What this trial is testing

Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury

Who this might be right for
Acute Spinal Cord Injury
Kringle Pharma, Inc. 25
Testing effectiveness (Phase 2)UnknownNCT05044988
What this trial is testing

HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer

Who this might be right for
HR+/HER2- Advanced and/or Metastatic Breast Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00000842
What this trial is testing

A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy

Who this might be right for
HIV InfectionsPeripheral Nervous System Disease
National Institute of Allergy and Infectious Diseases (NIAID) 270
Large-scale testing (Phase 3)Study completedNCT00446225
What this trial is testing

Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR

Who this might be right for
Non-Small Cell Lung Cancer
Spanish Lung Cancer Group 174
Not applicableStudy completedNCT02152124
What this trial is testing

Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?

Who this might be right for
Acromegaly
University Hospital, Ghent 21
Not applicableStudy completedNCT05696223
What this trial is testing

Doppler at the Diagnosis in Predicting Perinatal Outcomes in Early and Late-onset Fetal Growth Restriction

Who this might be right for
Fetal Growth Retardation
Central Hospital, Nancy, France 220
Testing effectiveness (Phase 2)WithdrawnNCT01479179
What this trial is testing

Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center
Not applicableUnknownNCT00867542
What this trial is testing

Dental and Oral Finding in Israeli Children With Past Intrauterine Growth Retardation (IUGR)

Who this might be right for
Dental Caries
Hadassah Medical Organization 45
Not applicableAvailableNCT06761976
What this trial is testing

Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 Mutation

Who this might be right for
Advanced Non-small Cell Lung CancerCancer
Bayer
Not applicableUnknownNCT05616117
What this trial is testing

Next-generation Effects of Vitamin D Supplementation in Pregnancy

Who this might be right for
GrowthVitamin D SupplementationImmune System Diseases+1 more
University of Aarhus 600
Post-approval studies (Phase 4)Study completedNCT00782197
What this trial is testing

Autologous Plasma Rich in Growth Factors (PRGF) Treating the Symptomatic Knee OA

Who this might be right for
Joint Disease
Biotechnology Institute IMASD 240
Large-scale testing (Phase 3)UnknownNCT05602090
What this trial is testing

Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials

Who this might be right for
Poor Ovarian Reserve
Beni-Suef University 120
Not applicableStudy completedNCT02907242
What this trial is testing

Revealed Versus Concealed Cerebroplacental Ratio

Who this might be right for
Stillbirth
Hospital Clinic of Barcelona 11,582
Early research (Phase 1)Study completedNCT00356460
What this trial is testing

Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Who this might be right for
Carcinoma, Renal CellMelanoma
Genzyme, a Sanofi Company 29
Testing effectiveness (Phase 2)UnknownNCT04974879
What this trial is testing

Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Qingdao Central Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01973660
What this trial is testing

PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 151
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06462079
What this trial is testing

Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain Metastases

Who this might be right for
Brain Metastasis
Guangzhou Medical University 43
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation